Design
Review
Authors
Loading...
Supports RNA helicase-targeted therapies in infection and disease; leaves open clinical adoption as markers or targets pending prospective trials.
Key points are not available for this paper at this time.
Steimer et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: